Psychometric validation study of the Simplicity of Diabetes Treatment Questionnaire (Sim-Q) across eight US clinical sites enrolling T2DM patients on diverse therapies including GLP-1 RAs and tirzepatide, assessing reliability, construct validity, and responsiveness to treatment change. Provides a validated patient-reported outcome measure for treatment simplicity in T2DM—enabling clinical trials and real-world studies to quantify how semaglutide's once-weekly injection impacts perceived treatment burden compared to daily oral agents or insulin regimens.
Boye, Kristina S; Cutts, Katelyn N; Coyne, Karin S; Matza, Louis S